查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1640535

水凝膠 -市場佔有率分析、產業趨勢與統計、成長預測（2025-2030 年）

Hydrogel - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計 2025 年水凝膠市場規模為 248 億美元，預計到 2030 年將達到 349.5 億美元，預測期內（2025-2030 年）的複合年成長率為 7.1%。

水凝膠-市場-IMG1

新冠肺炎疫情嚴重影響了水凝膠市場。全球封鎖和嚴格的政府規定導致我們大部分生產基地關閉，造成了毀滅性的打擊。儘管如此，自 2021 年以來業務一直在復甦，預計未來幾年將出現顯著上升。

關鍵亮點

  • 短期內，水凝膠在醫療產業的應用不斷擴大以及在農業產業的快速應用預計將推動市場成長。
  • 然而，水凝膠的高製造成本預計會阻礙市場的成長。
  • 水凝膠新應用領域的出現以及生物醫學和個人護理領域對水凝膠的認知和採用的提高預計將為研究市場帶來機會。
  • 亞太地區佔據全球水凝膠市場的最大佔有率，預計在預測期內將以最快的複合年成長率成長。

水凝膠市場趨勢

個人護理和衛生領域將佔據市場主導地位

  • 水凝膠非常適合用於衛生產品，因為它具有柔軟、類似組織的物理特性、優異的吸水性、良好的透氧滲透性、優異的生物相容性以及可用於額外運輸途徑的微孔結構。
  • 衛生產品的目標是製造更薄的墊片，在負載下具有更高的吸收性、更高的膨脹壓力和更大的吸力。因此，水凝膠因其特性是最合適的選擇。
  • 世界衛生組織（WHO）、世界銀行集團、聯合國兒童基金會和其他一些政府機構正在提高人們對衛生重要性的認知，特別是婦女和青春期女孩的月經衛生管理（MHM）。
  • 世界銀行集團在印度啟動了「清潔印度」運動下的旗艦衛生計畫。這項活動旨在提高當地社區包括男孩和男人的意識，消除圍繞月經的禁忌。
  • 此外，個人護理行業的電子商務銷售額也激增，市場參與企業包括寶潔公司、露華濃公司、Oliflame Cosmetics Global SA、雅芳公司和雅詩蘭黛公司。
  • 個人保健產品市場由幾家主要企業主導，包括歐萊雅、寶潔、聯合利華和資生堂。歐萊雅是所有公司中化妝品和個人護理銷售額最高的，2022 年銷售額約為 419.5 億美元。
  • 據個人護理協會歐洲化妝品協會 (Cosmetic Europe) 稱，每天有 5 億歐洲消費者使用化妝品和個人保健產品來保護自己的健康、增進幸福感並提高自尊。種類繁多，包括止汗劑、香水、化妝品、洗髮精、肥皂和防曬油。
  • Oberlo 表示，美國個人護理產業預計將在 2022 年成長 2.95%，預計 2023 年成長額將達到 422 億美元。預計這將刺激該國對水凝膠市場的需求。
  • 在預測期內，所有這些因素都可能推動全球個人護理和衛生產品市場對水凝膠的需求。

亞太地區佔市場主導地位

  • 由於中國、印度和日本等國家的個人護理和衛生、農業、製藥和醫療保健領域的成長，亞太地區佔據了全球市場佔有率的主導地位。
  • 根據ECHEMI預測，2022年中國醫藥產業預計將年增與前一年同期比較%左右。消化器官系統及代謝藥物約佔全國醫藥市場總量的14%。
  • 在中國，中產階級的壯大、人口老化、收入的提高和都市化進程的加速正在推動藥品銷售。根據CEIC資料，2022年6月中國醫藥銷售額為2,239.46億美元，高於2022年4月的1,460.41億美元。該國國內製藥業規模龐大且種類多樣，由約 5,000 家製造商和許多較小的公司組成。
  • 在全球製藥領域，印度是一個突出的擴張型新參與企業。根據PIB India統計，印度是全球領先的學名藥供應國，佔全球整體供應量的20%。印度藥品出口到200多個國家，其中美國是主要市場。
  • 據印度藥品出口促進委員會（Pharmexcil）總幹事稱，2021-22年，印度將出口價值17500.4億印度盧比（246.2億美元）的藥品，包括原料藥/醫藥中間體。此外，2022年4月至10月，印度醫藥出口成長4.22%，達145.7億美元。去年同期為139.8億美元。
  • 此外，根據印度品牌資產基金會的數據，到2030年印度製藥業的規模預計將達到1,300億美元。同時，預計到 2023年終全球醫藥產值將達到近 1 兆美元。
  • 因此，預計上述因素將在未來幾年增加對水凝膠的需求。

水凝膠產業概況

水凝膠市場細分化，少數公司佔相當大的佔有率。市場的主要企業（不分先後順序）包括 3M、強生服務公司、Cardinal Health、CooperVision 和 Smith & Nephew。

其他福利

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

目錄

第 1 章 簡介

  • 調查前提條件
  • 研究範圍

第2章調查方法

第3章執行摘要

第4章 市場動態

  • 驅動程式
    • 在醫療產業的應用日益廣泛
    • 農業領域採用率激增
    • 其他促進因素
  • 限制因素
    • 水凝膠製造成本高
    • 其他限制因素
  • 價值鏈分析
  • 波特五力分析
    • 消費者議價能力
    • 供應商的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭程度

第5章 市場區隔（市場規模（以金額為準））

  • 結構
    • 非晶質
    • 半結晶
    • 結晶質
  • 材料
    • 聚丙烯酸酯
    • 聚丙烯醯胺
    • 矽膠
    • 其他成分（瓊脂、明膠、PVP、PEG）
  • 最終用戶產業
    • 個人護理和衛生
    • 藥品和醫療保健
    • 食物
    • 農業
    • 其他最終用戶產業（法醫和調查）
  • 地區
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 其他亞太地區
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 義大利
      • 法國
      • 歐洲其他地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地區
    • 中東和非洲
      • 沙烏地阿拉伯
      • 南非
      • 其他中東和非洲地區

第6章 競爭格局

  • 併購、合資、合作與協議
  • 市場佔有率分析（%）**/排名分析
  • 主要企業策略
  • 公司簡介
    • 3M
    • Ambu A/S
    • Ashland
    • Axelgaard Manufacturing Co., Ltd.
    • Bausch Health Companies Inc.
    • Cardinal Health
    • Coloplast Corp.
    • ConvaTec Inc.
    • CooperVision
    • DSM
    • Essity Health & Medical
    • HOYA Corporation
    • Integra LifeSciences Corporation
    • Johnson & Johnson Medical Limited
    • Molnlycke Health Care AB
    • Medtronic
    • Novartis AG
    • PAUL HARTMANN Pty Ltd.
    • SEIKAGAKU CORPORATION
    • Sekisui Kasei Co. Ltd.
    • Smith & Nephew

第7章 市場機會與未來趨勢

  • 新的應用領域不斷湧現
  • 提高生物醫學和個人護理領域對水凝膠的認知和採用
  • 其他機會
簡介目錄
Product Code: 54436

The Hydrogel Market size is estimated at USD 24.80 billion in 2025, and is expected to reach USD 34.95 billion by 2030, at a CAGR of 7.1% during the forecast period (2025-2030).

Hydrogel - Market - IMG1

The COVID-19 pandemic harmed the hydrogel sector. Global lockdowns and severe rules enforced by governments resulted in a catastrophic setback as most production hubs were shut down. Nonetheless, the business has been recovering since 2021 and is expected to rise significantly in the coming years.

Key Highlights

  • Over the short term, the increasing application of hydrogel in the healthcare industry and the surge in adoption in the agriculture industry are expected to drive the market's growth.
  • However, the high production cost of hydrogel is expected to hinder the market's growth.
  • The emergence of a new application area for hydrogel and rising awareness and adoption of hydrogel in the biomedical and personal care sector will act as an opportunity for the market studied.
  • The Asia-Pacific region dominated the global hydrogel market with a significant share, and it is expected to register the fastest CAGR during the forecast period.

Hydrogel Market Trends

Personal Care and Hygiene Segment to Dominate the Market

  • Hydrogel is suitable for hygiene products due to its soft and tissue-like physical properties, superior water absorption, good oxygen permeability, superior biocompatibility, and micro-porous structure for additional transport channels.
  • Hygiene products aim to make thinner pads with higher absorbency under load, increased swelling pressure, and increased suction power. Hence, the hydrogel is the most suitable option due to its properties.
  • Several government organizations, such as the World Health Organization, World Bank Group, and UNICEF, are raising awareness about the importance of hygiene, especially menstrual hygiene management (MHM) for women and adolescent girls.
  • The World Bank Group initiated a flagship sanitation operation under the Swachh Bharath Mission in India. This operation aims to increase awareness among the community, including boys and men, to break the taboo around menstruation.
  • Further, the personal care industry is also expected to observe a surge in the number of young and independent brands, as e-commerce sales are surging and providing stiff competition to some of the major companies in the personal care industry, including Procter & Gamble, Revlon Inc. Oriflame Cosmetics Global SA, The Avon Company, The Estee Lauder Companies Inc., and Unilever.
  • The market for personal care products is dominated by a few key players, such as L'Oreal, Procter & Gamble, Unilever, and Shiseido Co., Ltd. L'Oreal has the highest cosmetics and personal care sales among the companies, and the company generated sales of around USD 41.95 billion in 2022.
  • According to Cosmetic Europe, the personal care association, Europe's 500 million consumers use cosmetic and personal care products every day to protect their health, enhance their well-being and boost their self-esteem. Ranging from antiperspirants, fragrances, make-up, shampoos, soaps, and sunscreens, to many others.
  • Oberlo stated that, in the United States, the personal care industry grew by 2.95% in 2022, and this growth is expected to outpace in 2023 to reach USD 42.2 billion. This is expected to stimulate the demand for the hydrogel market in the country.
  • Owing to all these factors, the personal care and hygiene products in the world may drive the demand for hydrogel during the forecast period.

Asia-Pacific Region to Dominate the Market

  • The Asia-Pacific region dominated the global market share due to the growing personal care and hygiene, agriculture, pharmaceuticals, and healthcare sectors in countries such as China, India, and Japan.
  • The pharmaceutical industry in China was anticipated to grow by about 17% year-on-year in 2022 stated by ECHEMI. Digestive and metabolic drugs account for around 14% of the total pharmaceutical market of the country.
  • The growing middle-class and aging population in China, rising incomes, and increasing urbanization drive pharmaceutical sales in the country. According to CEIC Data, the pharmaceutical sales revenue in China in June 2022 accounted for USD 223,946 million, up compared to USD 146,041 million in April 2022. The country has a large and diverse domestic drug industry, comprising around 5,000 manufacturers and many small or medium-sized companies.
  • In the global pharmaceuticals sector, India is a prominent and expanding player. According to PIB India, India is one of the world's major suppliers of generic medicines, accounting for 20% of the global supply by volume. Indian drugs are exported to more than 200 countries, with the United States being the key market.
  • According to the Director General of the Pharmaceutical Export Promotion Council of India (Pharmexcil), India exported INR 1,75,040 crore (USD 24.62 billion) worth of pharmaceutical products, including bulk drugs/drug intermediates, in FY2021-22. Furthermore, India's pharmaceutical exports increased by 4.22% from April to October 2022, reaching USD 14.57 billion. The exports were valued at USD 13.98 billion during the same period in the previous fiscal.
  • Further, according to Indian Brand Equity Foundation, by 2030, the Indian Pharma industry is expected to reach USD 130 billion. In contrast, global pharmaceutical production's revenue is forecasted to reach nearly USD 1 trillion by the end of 2023.
  • Therefore, the abovementioned factors are expected to increase the demand for hydrogel in the coming years.

Hydrogel Industry Overview

The hydrogel market is fragmented, with a few players holding a considerable share in the market. Some of the market's key players (not in any particular order) include 3M, Johnson & Johnson Services, Inc., Cardinal Health, CooperVision, and Smith & Nephew.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Increasing Application in the Healthcare Industry
    • 4.1.2 Surge in Adoption in Agriculture Industry
    • 4.1.3 Other Drivers
  • 4.2 Restraints
    • 4.2.1 High Production Cost of Hydrogel
    • 4.2.2 Other Restraints
  • 4.3 Industry Value Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Consumers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION (Market Size in Value)

  • 5.1 Structure
    • 5.1.1 Amorphous
    • 5.1.2 Semi-crystalline
    • 5.1.3 Crystalline
  • 5.2 Material
    • 5.2.1 Polyacrylate
    • 5.2.2 Polyacrylamide
    • 5.2.3 Silicone
    • 5.2.4 Other Materials (Agar, Gelatin, PVP, and PEG)
  • 5.3 End-user Industry
    • 5.3.1 Personal Care and Hygiene
    • 5.3.2 Pharmaceuticals and Healthcare
    • 5.3.3 Food
    • 5.3.4 Agriculture
    • 5.3.5 Other End-user Industries (Forensics and Research)
  • 5.4 Geography
    • 5.4.1 Asia-Pacific
      • 5.4.1.1 China
      • 5.4.1.2 India
      • 5.4.1.3 Japan
      • 5.4.1.4 South korea
      • 5.4.1.5 Rest of Asia-Pacific
    • 5.4.2 North America
      • 5.4.2.1 United States
      • 5.4.2.2 Canada
      • 5.4.2.3 Mexico
    • 5.4.3 Europe
      • 5.4.3.1 Germany
      • 5.4.3.2 United Kingdom
      • 5.4.3.3 Italy
      • 5.4.3.4 France
      • 5.4.3.5 Rest of Europe
    • 5.4.4 South America
      • 5.4.4.1 Brazil
      • 5.4.4.2 Argentina
      • 5.4.4.3 Rest of South America
    • 5.4.5 Middle-East and Africa
      • 5.4.5.1 Saudi Arabia
      • 5.4.5.2 South Africa
      • 5.4.5.3 Rest of Middle-East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share Analysis (%)**/Ranking Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 3M
    • 6.4.2 Ambu A/S
    • 6.4.3 Ashland
    • 6.4.4 Axelgaard Manufacturing Co., Ltd.
    • 6.4.5 Bausch Health Companies Inc.
    • 6.4.6 Cardinal Health
    • 6.4.7 Coloplast Corp.
    • 6.4.8 ConvaTec Inc.
    • 6.4.9 CooperVision
    • 6.4.10 DSM
    • 6.4.11 Essity Health & Medical
    • 6.4.12 HOYA Corporation
    • 6.4.13 Integra LifeSciences Corporation
    • 6.4.14 Johnson & Johnson Medical Limited
    • 6.4.15 Molnlycke Health Care AB
    • 6.4.16 Medtronic
    • 6.4.17 Novartis AG
    • 6.4.18 PAUL HARTMANN Pty Ltd.
    • 6.4.19 SEIKAGAKU CORPORATION
    • 6.4.20 Sekisui Kasei Co. Ltd.
    • 6.4.21 Smith & Nephew

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Emergence of New Application Areas
  • 7.2 Rising Awareness and Adoption of Hydrogel in Biomedical and Personal Care Sector
  • 7.3 Other Opportunities